Document:

EX-10.1

 Exhibit 10.1 

SEPARATION AGREEMENT AND GENERAL RELEASE 

This Separation Agreement and General Release (“Agreement”) is made between Mondelēz Global LLC (and any currently or
previously-affiliated companies, parent companies, successors or predecessors, including Mondelēz International, Inc., Kraft Foods Inc., Kraft Foods Group, Inc., and Kraft Foods Global, Inc., hereafter, collectively referred to herein as,
“MG” or the “Employer”) and Brian Gladden (“Gladden” or the “Employee”) (the Employer and Employee are collectively referred to herein as the “Parties”). 

Gladden has been employed by MG as EVP and Chief Financial Officer of Mondelēz International, Inc. 

In connection with Gladden’s employment with MG, Gladden executed an offer letter dated September 26, 2014 (the “Offer
Letter”), which Offer Letter is incorporated into this Agreement by reference and made a part hereof as if set forth in full. 
 In
connection with Gladden’s employment with MG, Gladden also executed several Grant Agreements (the “Grant Agreements”), dated February 18, 2015; February 22, 2016; February 16, 2017; August 1, 2017; and
February 22, 2018; which Grant Agreements are incorporated into this Agreement by reference and made a part hereof as if set forth in full. 

Since Gladden’s employment relationship with MG is ending, MG has offered Gladden benefits as set forth in this Agreement, and Gladden
has decided to accept MG’s offer. Therefore, Gladden and MG both agree and promise as follows: 

1.    Employment Termination: Gladden’s last day of employment with MG is July 31, 2018
(“Last Day Worked” or “Termination Date”). Gladden will be paid for any accrued, unused 2018 PTO days, less applicable deductions, at the next normal payday following the Termination Date. After the Termination Date, Gladden will
not represent himself as being an employee, officer, attorney, agent or representative of MG for any purpose. 

2.    Sufficiency of Consideration: Gladden understands, acknowledges and agrees that the payment of
benefits described in this Agreement, including payments and benefits described in Section 3 herein, are conditioned upon his execution and non-revocation of this Agreement and are, in significant and
substantial part, in addition to those benefits to which he is otherwise entitled. Gladden acknowledges and agrees that MG has – apart from this Agreement – paid him for all wages that were due to him. 

3.    Consideration: In exchange for the promises and releases in this Agreement, and provided
Gladden does not revoke the Agreement as permitted in Section 14 below, MG will provide Gladden with the following benefits and payments: 

a)    Gladden will receive a pro-rated 2018 Management Incentive Plan
(“MIP”) award based on the number of days worked from January 1, 2018 through the Last Day Worked, to be paid at actual performance for the individual performance component and actual performance for the Company performance component.
This payment, less applicable deductions, will be made no later than March 15, 2019. Gladden will not be eligible to receive any other MIP payments. 

b)    Subject to the underlying terms and conditions of the applicable plans, Gladden will receive compensation and
benefits as provided for under MG’s retirement and benefits plans available to employees generally. Gladden will not be entitled to any other compensation or benefits not provided in this Agreement, nor is Gladden entitled to any severance
under the Mondelēz Global LLC Severance Pay Plan for Salaried Exempt Employees. For avoidance of doubt, all outstanding unvested equity awards will be forfeit upon Gladden’s Last Day Worked and all vested stock options will expire 30 days
from his Last Day Worked. Gladden may revoke this Agreement within seven (7) days after he signs it by giving written notice to MG. To be effective, this revocation 

 
must be received by the close of business on the 7th calendar day after Gladden signs this Agreement. If Gladden revokes this Agreement, he understands that he will not receive the benefits that
are conditioned upon his execution of the Agreement. This Agreement will not become effective or enforceable unless and until the seven-day revocation period has expired without Gladden revoking it. 

4.    Complete Release and Waiver of Claims: 

a)    Gladden is aware of his legal rights concerning his employment with MG. In exchange for MG’s promises above,
Gladden agrees to irrevocably and unconditionally release (i.e. give up) any and all claims he may now have against, and agrees not to sue, MG and any currently or previously-affiliated companies, parent companies, successors or predecessors,
and their officers, directors, agents and employees, including without limitation those arising out of the employment relationship between Gladden and MG (the “Release”). This Release includes, but is not limited to, all claims under Title
VII of the Civil Rights Acts of 1964 and 1991, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Family and Medical Leave Act, the Fair Labor Standards Act, the Sarbanes-Oxley Act of 2002, the Employee Retirement
Income Security Act, the Illinois Human Rights Act, the Right to Privacy in the Workplace Act, the Illinois Health and Safety Act, the Illinois Employment Contract Act, the Illinois Whistleblower Act, and any other federal, state or local law, as
well as any claims for breach of contract, wrongful discharge, and tort claims; claims for wages, benefits or severance pay; claims for attorneys’ fees; and any other claim or action whatsoever. This general release and waiver does not contain
a waiver of rights or claims that may arise after the date the Agreement is executed by Gladden, and also excludes any claims which cannot be waived by law. For the avoidance of doubt, payments made pursuant to this Agreement remain subject to any
recovery, recoupment, clawback and/or other forfeiture policy maintained by MG or any affiliate. 

b)    Specific Release of ADEA Claims: In further consideration of the payments and benefits
provided to the Employee in this Agreement, Gladden hereby irrevocably and unconditionally fully and forever waives, releases and discharges MG from any and all claims, whether known or unknown, from the beginning of time to the date of
Gladden’s execution of this Agreement, arising under the Age Discrimination in Employment Act (ADEA), as amended, and its implementing regulations. 

5.    Right to Participate in Agency Proceedings: Nothing in this Agreement is intended to limit or
impair in any way Gladden’s right to file a charge with the U.S. Equal Employment Opportunity Commission (EEOC) or comparable state and local fair employment practices agencies (FEPAs), or Gladden’s right to participate in any such charge
filed with such agencies. 
 6.    Cooperation: The Parties agree that certain matters in which
Gladden has been involved during his employment may necessitate Gladden’s cooperation with MG in the future. Accordingly, for a period of two (2) years following the Termination Date, to the extent reasonably requested by MG and
upon reasonable notice, Gladden shall cooperate with MG in connection with matters arising out of Gladden’s service to the Employer, including those legal matters, both known and unknown, about which Gladden has personal knowledge and/or may be
called as a witness; provided that MG shall make reasonable efforts to minimize disruption of Gladden’s other activities. MG shall reimburse Gladden for reasonable expenses incurred in connection with his cooperation 

7.    Restrictive Covenants: 

(a)    Non-Competition: Gladden understands and agrees that the nature of
his position with MG gave him access to and knowledge of highly confidential information and trade secrets of MG, and placed him in a position of trust and confidence with MG. Because of MG’s legitimate business interests and in consideration
for MG’s payment/provision to Gladden of the amounts and benefits provided in Section 3 above, for the twelve (12)-month period following the Termination Date (“Restricted Period”) and in any geographic area in which Gladden
directly or indirectly performed responsibilities for MG or where his knowledge of Confidential Information (as defined in Section 10, infra) would be useful to a competitor in competing against MG, Gladden shall not engage in any
conduct in which he contributes his knowledge and skills, directly or indirectly, in whole or in part, as an executive, employer, owner, operator, manager, advisor, consultant, agent, partner, director,

 
stockholder, officer, volunteer, intern or any other similar capacity to a competitor or to an entity engaged in the same or similar business as MG, including those engaged in the business of
production, sale or marketing of snack foods (including, but not limited to gum, chocolate, confectionary products, biscuits or any other product or service Gladden had reason to know was under development by MG during his employment with MG),
limited solely to those competitors or entities that have a material business in snack foods (where “material” is defined as $50MM or more in annual retail sales), without the written consent of MG’s Executive Vice President of Global
Human Resources, or designee, such consent to be provided by MG in its sole and absolute discretion. For the purpose of this Section 7(a), MG’s competitors include entities engaged in the same or similar business as wholly owned
subsidiaries of Mondelēz International, Inc. For purposes of this Non-Competition clause, Listed Competitors include, but are not limited to, the following companies: PepsiCo, Inc., Campbell Soup Company,
The Coca-Cola Company, Kellogg Company, Mars, Inc., Nestle S.A., Ferrero Rocher, General Mills, Inc., The Hershey Company, Groupe Danone, Perfetti Van Melle, Arcor, Unilever Group, Lindt & Sprungli AG, and Yildiz Holding A.S., or any
subsidiaries, affiliates or subsequent parent or merger partner, if any of these companies are acquired or become part of a merger. For purposes of this Agreement, “affiliate” of a specified person or entity means a person or entity that
directly or indirectly controls, is controlled by, or is under common control with, the person or entity specified. For the avoidance of doubt, during the Restricted Period, Gladden shall not advise any client or potential client on any matters or
in any manner that would be useful to that client or potential client in competing against MG, or that would cause a client or potential client to become a competitor to MG. Passive ownership of less than two percent (2%) of the outstanding stock of
any publicly traded corporation (or private company through an investment in a hedge fund, or similar vehicle) shall not be deemed to be a violation of this Section 7(a) solely by reason thereof. Under no circumstances may Gladden engage in any
activity that may require or inevitably require his use or disclosure of MG’s Confidential Information. 

(b)    Non-Solicitation of Employees: Gladden understands and acknowledges
that MG has expended and continues to expend significant time and expense recruiting and training its employees and that the loss of employees would cause significant and irreparable harm to MG. Gladden agrees and covenants not to directly or
indirectly solicit, hire, recruit, attempt to hire or recruit, or induce the termination of employment of any employee of MG during the Restricted Period. The foregoing shall not be violated by general advertising not targeted at MG employees or by
serving as a reference upon request. 
 (c)    Restrictive Covenant Remedies: If Gladden breaches or violates
the provisions of this Section 7, he will be obligated to pay back to MG all payments received pursuant to this Agreement, and MG will not be obligated to make any future payments pursuant to this Agreement that are otherwise owed. This will be
in addition to any other remedy that MG may have in respect of such Prohibited Conduct. MG and Gladden acknowledge and agree that MG will or would suffer irreparable injury in the event of a breach or violation or threatened breach or violation of
the provisions set forth in this Section 7, and agree that in the event of a breach or violation of such provisions MG will be awarded injunctive relief by a Court of competent jurisdiction to prohibit any such breach or violation, and that
such right to injunctive relief will be in addition to any other remedy which may be ordered by the Court or an arbitrator. The aforementioned equitable relief shall be in addition to, not in lieu of, legal remedies, monetary damages or any other
available forms of relief. 
 (d)    Judicial Amendment: Gladden and MG acknowledge the reasonableness of the
agreements set forth in this Section 7 and the specifically acknowledge the reasonableness of the geographic area, duration of time and subject matter that are part of the covenant not to compete contained in Section 7(a)(i)-(ii). Gladden
further acknowledges that Gladden’s skills are such that Gladden can be gainfully employed in noncompetitive employment and that the parties’ agreement not to compete will in no manner prevent Gladden from earning a living. Notwithstanding
the foregoing, in the event it is judicially determined that any of the limitations contained in this Section 7 are unreasonable, illegal or offensive under any applicable law and may not be enforced as agreed herein, the parties agree that the
unreasonable, illegal or offensive portions of this Section 7, whether they relate to duration, area or subject matter, shall be and hereby are revised to conform with all applicable laws and that this Agreement, as modified, shall remain in
full force and effect and shall not be rendered void or illegal. 
 8.    This Agreement to Be Kept
Confidential: Gladden understands that this Agreement is unique to him and he agrees that it is confidential and that he will not disclose this Agreement or its terms to anyone other than (a) his legal or tax advisor,
(b) his immediate family, (c) in a legal action to enforce the terms of this Agreement, (d) the EEOC or similar state or local FEPA in connection with the filing or investigation of a charge, or (e) as ordered or required by law.
Gladden further agrees that if he discloses the existence of terms of this Agreement to anyone under (a) or (b) above, he will inform them of the confidentiality requirements of this Section and require that they agree to be bound by such
requirements. Nothing in this Section 8 shall be construed to prohibit Gladden from reporting conduct to, providing truthful information to or participating in any investigation or proceeding conducted by any federal, state or local government
agency or self-regulatory organization. 

 9.    No Disparagement or Harm: Gladden agrees
that, in discussing his relationship with MG and its affiliated and parent companies and their business and affairs, he will not disparage, discredit or otherwise treat in a detrimental manner MG, its affiliated and parent companies or their current
or former officers, directors and employees. This Section 9 does not, in any way, restrict or impede Gladden from exercising protected rights including the right to communicate with any federal, state, or local agency or self-regulatory
organization, including any with which a charge has been filed, to the extent that such rights cannot be waived by agreement, or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an
authorized government agency, provided that such compliance does not exceed that required by the law, regulation or order. To the extent legally permissible, Gladden shall promptly provide written notice of any such order to MG’s legal
department. 
 10.    Continuing Confidentiality Obligation: Gladden acknowledges that during the
course of his employment with MG, he has had access to, learned about and was entrusted with certain confidential and secret financial, strategy, sales, marketing, product, manufacturing, labor relations, personnel, technical and other proprietary
information and material (“Confidential Information”) which are the property of MG. Gladden understands that the above list is not exhaustive, and that Confidential Information also includes other information that is marked or otherwise
identified as confidential or proprietary, or that would otherwise appear to a reasonable person to be confidential or proprietary in the context and circumstances in which the information is known or used. Gladden further understands and
acknowledges that this Confidential Information and MG’s ability to reserve it for the exclusive knowledge and use of MG is of great competitive importance and commercial value to MG, and that improper use or disclosure of the Confidential
Information by Gladden might cause MG to incur financial costs, loss of business advantage, liability under confidentiality agreements with third parties, civil damages and criminal penalties. Gladden agrees that, from the date he is presented with
this Agreement and following the Terminate Date, he will not communicate or disclose to any third party, or use for his own account, without the written consent of MG, any of the aforementioned information or material. 

If MG becomes aware of a situation where it appears that its trade secrets are being used and/or disclosed by Gladden, it will enforce its
rights to the fullest degree allowed by law, including Federal or State trade secret law. An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in
confidence to a Federal, State, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law. An individual shall not be held criminally or civilly liable under any Federal or State
trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. An individual who files a lawsuit for retaliation by an employer for
reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal; and
does not disclose the trade secret, except pursuant to court order. 
 11.    Protected Rights:
Gladden understands that nothing contained in this Agreement limits Gladden’s ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health
Administration, the Securities and Exchange Commission, or any other federal, state or local governmental agency or commission (“Government Agencies”). Gladden further understands that this Agreement does not limit Gladden’s ability
to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. This Agreement
does not limit Gladden’s right to receive an award for information provided to any Government Agencies. 

 12.    Return of Company Property: Gladden agrees
to return all Company property in his possession, including documents, manuals, identification cards or badges, laptops, computers, telephones, mobile phones, hand-held electronic devices, credit cards, electronically stored documents or files,
physical files, handbooks, notes, keys and any other articles he has used in the course of his employment and any other Company property in his possession, no later than the Last Day Worked. 

13.    Arbitration of Claims: In the event either Gladden or MG contests the interpretation or
application of any of the terms of this Agreement, the complaining party shall notify the other in writing of the provision that is being contested. If the Parties cannot satisfactorily resolve the dispute within thirty (30) days, the matter
will be submitted to arbitration with JAMS (f.k.a. Judicial Arbitration and Mediation Services, Inc.). The arbitration will be conducted, and an arbitrator will be chosen, pursuant to the JAMS Employment Arbitration Rules and Procedures. The
arbitrator’s fees and expenses and filing fees shall be borne by the losing (non-prevailing) Party. The hearing shall be held at a location selected by MG, and the arbitrator shall issue a written award
which shall be final and binding upon the Parties. Gladden agrees to waive the right to a jury trial. Notwithstanding anything contained in this Section 13 or Section 7(c) to the contrary, MG shall each have the right to institute judicial
proceedings against Gladden or anyone acting by, through or under Gladden, in order to enforce its rights under Sections 6, 7, 8, 9 or 10 through specific performance, injunction, or similar equitable relief. Claims not covered by arbitration
are those claims seeking injunctive and other relief due to unfair competition, due to the use or unauthorized disclosure of trade secrets or confidential information set forth in Sections 8 or 10, or breach of restrictive covenants set forth in
Section 7. 
 14.    Review and Revocation: Gladden acknowledges that, before signing this
Agreement, MG gave him a period of twenty-one (21) days in which to consider it. Gladden further acknowledges that: (a) he took advantage of this period to consider this Agreement before signing it;
(b) he has carefully read this Agreement, and each of its provisions; (c) to the extent Gladden had any, Gladden resolved all of his doubts and concerns regarding representations being made in this Agreement before signing it;
(d) Gladden fully understands what the Agreement, and each of its provisions, means; and (e) Gladden is entering into the Agreement, and each of its provisions, knowingly and voluntarily. MG encouraged Gladden to discuss this Agreement,
and each of its provisions, with an attorney (at his own expense) before signing it. Gladden acknowledges that he sought such advice to the extent he deemed appropriate. If Gladden signs this Agreement before the end of the twenty-one (21) day period, Gladden does so voluntarily because he has decided that he does not need any additional time to decide whether to sign this Agreement. Gladden also understands that he does not have
more than twenty-one (21) days to sign this Agreement. If Gladden does not sign this Agreement by the end of the twenty-one (21) day period, he understands
that it will become null and void. Gladden also acknowledges and understands that MG would not have given him the special payments or benefits he is getting in exchange for this Agreement but for his promises and representations he made by signing
it. Further, by signing below, Gladden acknowledges that he may revoke this Agreement at any time within seven (7) days of the date on which he signed it as described above in Section 3(b). 

15.    Entire Agreement and Severability: This is the entire agreement between Gladden and MG on the
subject matter of this Agreement. This Agreement may not be modified or canceled in any manner except by a writing signed by both Gladden and an authorized Company official. Gladden acknowledges that MG has made no representations or promises to
her, other than those in this Agreement. If any provision in this Agreement is found to be unenforceable, all other provisions will remain fully enforceable. The covenants set forth in this Agreement shall be considered and construed as separate and
independent covenants. Should any part or provision of any provision of this Agreement be held invalid, void or unenforceable in any court of competent jurisdiction, such invalidity, voidness or unenforceability shall not render invalid, void or
unenforceable any other part or provision of this Agreement. If the release and waiver of claims provisions of this Agreement are held to be unenforceable, the parties agree to enter into a release and waiver agreement that is enforceable. 

 16.    Governing Law: This Agreement, for all
purposes, shall be governed under and construed in accordance with the laws of the State of Illinois without giving effect to any choice of law or conflict of law provision or rule that would cause the application of the laws of any jurisdiction
other than Illinois. For any application for injunctive relief, and in the event a dispute between the Parties is not subject to arbitration under Section 13, any action or proceeding by either of the Parties to enforce this Agreement shall be
brought only in a State or Federal court located in the State of Illinois. The Parties consent to the personal jurisdiction of such courts and agrees not to claim that any such courts are inconvenient or otherwise inappropriate. 

17.    Section 409A: This Agreement is intended to comply with Section 409A of the Internal
Revenue Code of 1986, as amended (“Section 409A”) or an exemption thereunder and shall be construed and administered in accordance with Section 409A. Notwithstanding any other provision of this Agreement, payments subject to
Section 409A provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. Any payments under this Agreement that may be excluded from Section 409A either as
separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided under this
Agreement shall be treated as a separate payment. Any payments to be made under this Agreement upon a termination of employment shall only be made upon a “separation from service” under Section 409A. Gladden will be deemed to have
incurred a separation from service under Section 409A the day immediately following his Last Day Worked. 
 In the event that Gladden
is a “specified employee” within the meaning of Section 409A, to the extent required in order to comply with Section 409A, any amounts or benefits to be paid or provided to Gladden pursuant to this Agreement or otherwise that are
considered nonqualified deferred compensation under Section 409A will be delayed six (6) months to the first business day on which such amounts and benefits may be paid in compliance with said Section 409A. 

Notwithstanding the foregoing, MG makes no representations that the payments and benefits provided under this Agreement comply with
Section 409A, and in no event shall MG be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by Gladden on account of non-compliance with
Section 409A. 
 [SIGNATURE PAGE FOLLOWS] 

 
TAKE THIS AGREEMENT HOME, READ IT, AND CAREFULLY CONSIDER ALL OF ITS PROVISIONS BEFORE SIGNING IT: IT
INCLUDES A RELEASE OF KNOWN AND UNKNOWN CLAIMS. IF YOU WISH, YOU SHOULD TAKE ADVANTAGE OF THE FULL CONSIDERATION PERIOD AFFORDED BY SECTION 14 AND YOU SHOULD CONSULT WITH AN ATTORNEY PRIOR TO EXECUTING THIS AGREEMENT. 

 

			
	MONDELĒZ GLOBAL LLC:
		
	By:	 	/s/ David H. Pendleton
		
	Title:	 	SVP Total Rewards and HR Solutions
		
	Date:	 	August 13, 2018

  

			
	BRIAN GLADDEN:
		
	Signature:	 	/s/Brian T. Gladden
		
	Print Name:	 	Brian T. Gladden
		
	Date:	 	August 13, 2018Exhibit 4.2

 

CREATIVE LEARNING CORPORATION

NON-QUALIFIED STOCK OPTION PLAN

 

I.          Purpose

 

Creative Learning
Corporation, a Delaware corporation (the “Company”), desires to attract and retain the best available personnel and
to enhance the long-term growth of the Company’s earnings. The Company believes it will achieve its goals most effectively
by providing key individuals with long-term incentives based upon the growth of the value per share of the Company’s stock.

 

II.         Scope

 

The Company is adopting
the stock option plan (the “Plan”) to provide Non-Qualified Stock Options (collectively, the “Options”
and individually, an “Option”) to the Company’s [Chairman, President/CEO, Vice Presidents and Board of Directors]
(the “Participants” or a “Participant”).

 

Initially, the Company
will reserve 1,800,000 shares of its common stock, par value $.0001 per share (the “Shares” or a “Share”),
for issuance under the Plan.

 

III.       Administration

 

This Plan will be
administered by the Company’s Compensation Committee (the “Committee”).

 

IV.       Eligibility

 

Awards may be made
to any Participant selected by the Committee.

 

V.        Option
Price

 

The purchase price
of each Share subject to an Option shall be its Fair Market Value (defined below) at the date the Option is granted (“Option
Price”), as defined in IRS Regulations under Internal Revenue Code Section 409A.

 

Fair Market Value
means the last sales price reported for the Shares on the applicable date as reported on the principal national securities exchange
in the United States on which it is then traded, or, if such date is not a trading day, the last prior day on which the Shares
were so traded; or if not so listed, the mean between the closing bid and asked prices of publicly traded Shares in the over-the-counter
market, or, if such bid and asked prices shall not be available, as reported by any nationally recognized quotation service selected
by the Committee.

 

     

     

    

 

VI.       Option
Grants

 

A.        Option
Grants. The grant of an Option under this Plan will be evidenced by an option agreement (the “Option Agreement”)
between the Company and the Participant granted an Option (the “Optionee”) in a form approved by the Committee. The
Option Agreement will contain the terms set forth in this Plan and such additional terms and conditions as may be prescribed by
the Committee from time to time.

 

B.         Committee
Determinations. The Committee designates those Participants to whom Options are granted and the number of Shares represented
by the Option.

 

 The Committee
will have the discretion to provide additional Options as it determines.

 

VII.     Vesting
of Options

 

 Unless otherwise
determined by the Committee at grant, all options granted to a Participant shall vest in four equal annual installments commencing
on the date of grant.

 

VIII.    Maximum
Term; Exercise of Options

 

 Options shall
be exercised on or before the date which is 10 years after the date of grant. Thereafter, such Options shall expire. Upon vesting,
Options may be exercised by the Optionee or, in the event of the death or total disability (as hereinafter defined) of the Optionee
by the Optionee’s guardian, legal representative or designated beneficiary, at any time before the date of the expiration
or earlier termination of the Options. The Option Price may be paid in cash or by delivery of Shares owned by the Optionee having
a Fair Market Value (as defined in Section V., above) equal to the Option Price or in a combination of cash and Shares having
a Fair Market Value (as defined in Section V., above) as of the date of exercise equal to the Option Price.

 

IX.      Effect
of Death, Disability or Other Events on Vesting

 

 In the event
an Optionee dies or suffers a “total disability,” or upon Other Events, the Optionee will vest 100% in the Options
he or she has been granted. In such event, the Optionee, the Optionee’s guardian, legal representative or designated beneficiary
shall have 90 days to exercise any Options vested on the date of the event. All Options which are unexercised within 90 days after
death, “total disability,” or upon Other Events shall be forfeited.

 

 For purposes
of this Plan, the term “total disability” shall mean the inability of a Participant to engage in his usual and customary
employment with the Company by reason of any medically determinable physical or mental impairment, which in the opinion of the
Committee, can be expected to result in death or to last for a continuous period of at least twelve months. The term “Other
Events” shall mean (i) the sale, exchange, transfer or other disposition of substantially all of the Company’s assets,
except to an entity, controlled, directly or indirectly, by the Company; or (ii) a merger, consolidation or other reorganization
of the Company, except where the resulting entity is controlled, directly or indirectly, by the Company or where the shareholders
of the Company immediately prior to consummation of any such transaction continue to hold at least a majority of the voting power
of the outstanding voting securities of the legal entity resulting from such transaction.

 

    2 

     

    

 

X.        Exercise
on Termination of Employment

 

 Upon a termination
of an Optionee’s employment relationship with the Company for any reason other than death or “total disability”
or if a director Optionee ceases to be a director of the Company, he or she shall have 90 days to exercise any Option vested on
the date of termination. All Options which are non-vested on the date of termination shall be forfeited and all vested Options
which are unexercised within 90 days after termination shall be forfeited.

 

XI.       Changes
in Company’s Capital Structure

 

 The existence
of outstanding Options shall not affect in any way the right or power of the Company or its stockholders to make or authorize
any or all adjustments, recapitalization, reorganizations, exchanges, or other changes in the Company’s capital structure
or its business, or any merger or consolidation of the Company, or any issuance of common stock or other securities or subscription
rights thereto, or any issuance of bonds, debentures, preferred or prior preference stock ahead of or affecting the Shares or
the rights thereof, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets
or business, or any other corporate act or proceeding, whether of a similar character or otherwise. However, if outstanding Shares
for which an Option is exercisable shall at any time be changed or exchanged by declaration of a stock dividend, stock split,
combination of shares, recapitalization, or reorganization, the number of Shares subject to Options, and the Option Price, shall
be appropriately and equitably adjusted so as to maintain the proportionate number of shares or other securities without changing
the aggregate Option Price.

 

XII.     Change
of Control

 

(a)       Change
of Control: means that (A) the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise,
in one or more related transactions, (i) consolidate or merge with or into another Person, Persons or “group” (as
that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Act”) and as defined in
Rule 13d-5 thereunder) or any Affiliate or associate of any such Person, Persons or group (“Subject Entity”) where
the holders of a majority of the Company’s outstanding Shares immediately prior to the consolidation or merger do not continue
to own at least 50.1% of the surviving corporation, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially
all of the properties and assets of the Company and its subsidiaries, or (iii) make, or be subject to or have the Shares be subject
to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at
least either (x) 50.1% of the outstanding Shares, or (y) such number of Shares such that all Subject Entities making or party
to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively the
beneficial owners (as defined in Rule 13d-3 under the Act) of at least 50.1% of the outstanding Shares, or (iv) consummate a stock
purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate,
acquire, either (x) at least 50.1% of the outstanding Shares, or (y) such number of Shares such that the Subject Entities become
collectively the beneficial owners (as defined in Rule 13d-3 under the Act) of at least 50.1% of the outstanding Shares, or (v)
reorganize, recapitalize or reclassify its common stock or effect a compulsory share exchange pursuant to which the common stock
is effectively converted into or exchanged for other securities, cash or property, or (vi) the execution by the Company or any
subsidiary of a definitive agreement directly or indirectly providing for any of the foregoing events, (B) any Subject Entity
individually or the Subject Entities in the aggregate is or shall become the “beneficial owner” (as defined in Rule
13d-3 under the Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer,
exchange, reduction in outstanding Shares, merger, consolidation, business combination, reorganization, recapitalization, spin-off,
scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x)
at least 50.1% of the aggregate ordinary voting power of the Company’s capital securities (as determined on an as-converted
to common stock basis), or (y) a percentage of the aggregate ordinary voting power represented by issued and outstanding Shares
or other equity securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or
other transaction requiring other stockholders of the Company to surrender their Shares without approval of the stockholders of
the Company, (C) the current directors of the Board as of the date hereof cease to constitute more than a majority of the members
of the Board, or (D) the issuance of or the entering into any other instrument or transaction structured in a manner to
circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed and implemented
in a manner otherwise than in strict conformity with the terms hereof to the extent necessary to correct this definition or any
portion hereof which may be defective or inconsistent with the intended treatment of such instrument or transaction.

 

    3 

     

    

 

(b)       Impact
of Change of Control. In the event of a Change of Control after the Effective Date (as hereinafter defined), the Committee may
provide for (i) the termination of an Option upon the consummation of the Change of Control, but only if such Option has vested
and been paid out or the Participant has been permitted to exercise the Option in full for a period of not less than 10 days prior
to the Change of Control, (ii) acceleration of all or any portion of an Option, (iii) the payment of any amount (in cash or, in
the discretion of the Committee, in the form of consideration paid to shareholders of the Company in connection with such Change
of Control) in exchange for the cancellation of such Option which may equal the excess, if any, of the Fair Market Value of the
Shares subject to such Options over the Option Price, and/or (iv) issuance of substitute Options that will substantially preserve
the otherwise applicable terms of any affected Options previously granted hereunder.

 

XIII.      No
Right to Company Employment

 

Nothing in this Plan
or as a result of any Option granted pursuant to this Plan shall confer on any individual any right to continue in the employ
of the Company or interfere in any way with the right of the Company to terminate an individual’s employment at any time.

 

    4 

     

    

 

XIV.       Amendment
or Termination of Plan

 

The Committee may at
any time from time to time amend the Plan, or may terminate this Plan.

 

XV.        Option
Grants are Discretionary

 

The grant of any Option
is entirely discretionary and nothing in this Plan shall be deemed to give any employee any right to receive Options not specifically
granted by the Committee.

 

XVI.       Liability

 

No member of the Committee
shall be liable for any act or omission relating to the administration of the Plan, except for acts which constitute gross negligence
or willful misconduct.

 

XVII.      Effective
Date

 

This Plan is effective
as of August 17, 2018 (the “Effective Date”).

 

IN WITNESS WHEREOF,
the Company has caused the Plan to be executed effective as of August 17, 2018.

 

	 	CREATIVE LEARNING CORPORATION
	 	 
	 	By:	/s/ Christian Miller
	 	 	Name:	 Christian Miller
	 	 	Title:	 Chief Financial Officer

 

    5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]